how does semaglutide help your heart and Cardiovascular Health Why Your Cardiologist May Prescribe

3.5% with Wegovy Discontinuation due to adverse events: 6 patients in each group The similar safety profiles suggest that for most patients, the choice between Zepbound vs Wegovy can focus primarily on effectiveness and individual response rather than safety concerns

Most patients find neither significantly painful, though individual sensitivity varies

The proportion of subjects with prior HF in this analysis (~15%) is similar to the proportions in the prespecified subgroup analyses of LEADER2 and EXSCEL,35 in which the CIs also spanned 1.0

[DOI] [PubMed] [Google Scholar] [4].Viby N-E, Isidor MS, Buggeskov KB, et al

[DOI] [PMC free article] [PubMed] [Google Scholar] 231.van der Louw EJ, Williams TJ, Henry-Barron BJ, et al

In SURMOUNT-1, at the 15 mg dose over 72 weeks, 91% of participants lost at least 5% of their body weight, 83.5% lost at least 10%, 70.6% lost at least 15%, and 56.7% lost at least 20%